Clinical Trial to Treat Gliosarcoma or Primary CNS Sarcoma

Clinical Trial to Treat Gliosarcoma or Primary CNS Sarcoma

04/12/2020 06:39 AM EDT

Neuro-oncologist Mark Gilbert, M.D., shares information about a clinical trial at NIH investigating the effectiveness of a cancer drug to treat people with gliosarcoma or primary sarcoma of the central nervous system. He explains the goal of the trial, who can participate and how, and what a patient can expect. Trial ID: 18-C-0137. Learn more at www.cancer.gov/clinicaltrials/NCI-2018-03715.